The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ALPS ETF TR ALERIAN MLP 00162Q452 1,079 29,500 SH   SOLE   29,500 0 0
ARCELLX INC COMMON STOCK 03940C100 1,430 76,186 SH   SOLE   76,186 0 0
BRIDGETOWN HOLDINGS LTD *W EXP 09/30/202 G1355U121 5 39,773 SH   SOLE   39,773 0 0
EIGER BIOPHARMACEUTICALS INC COM 28249U105 880 116,884 SH   SOLE   116,884 0 0
ELEVATION ONCOLOGY INC COM 28623U101 77 68,297 SH   SOLE   68,297 0 0
FRAZIER LIFESCIENCES ACQU CO *W EXP 11/30/202 G3710A113 17 21,333 SH   SOLE   21,333 0 0
LUX HEALTH TECH ACQUISITION *W EXP 11/30/202 55068A118 9 66,666 SH   SOLE   66,666 0 0
MOLECULAR TEMPLATES INC COM 608550109 1,539 2,052,991 SH   SOLE   2,052,991 0 0
PRIMAVERA CAPITAL ACQUIST CO *W EXP 01/19/202 G7255E117 2 12,000 SH   SOLE   12,000 0 0
REZOLUTE INC COM NEW 76200L309 3,845 1,403,157 SH   SOLE   1,403,157 0 0
SAVARA INC COM 805111101 10,690 6,896,551 SH   SOLE   6,896,551 0 0
SCYNEXIS INC COM NEW 811292200 4,137 1,723,947 SH   SOLE   1,723,947 0 0
SPDR S&P 500 ETF TR TR UNIT 78462F103 5,696 15,947 SH   SOLE   15,947 0 0
SPDR SER TR S&P OILGAS EXP 78468R556 2,183 17,500 SH   SOLE   17,500 0 0
UNITED STS OIL FD LP UNITS 91232N207 11,326 173,500 SH Call SOLE   173,500 0 0
VECTIVBIO HLDG AG ORD SHS H9060V101 845 140,863 SH   SOLE   140,863 0 0
XERIS BIOPHARMA HOLDINGS INC COM 98422E103 9,421 6,039,028 SH   SOLE   6,039,028 0 0